Background illustration for clinical trials search

Paid Clinical Trials Irving

Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

for
Heart Transplant, Heart Failure, Transplant; Failure, Heart
Location: Dallas TX, St Louis MO, Omaha NE, Nashville TN,
Sponsor: XVIVO Perfusion

Sex: All

Age: 18+

Code: NCT06895070

Recruiting

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

for
Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases
Location: Dallas TX, Houston TX, San Antonio TX, Little Rock AR,
Sponsor: Duke University

Sex: All

Age: 70+

Code: NCT04262206

Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Dallas TX, Westwood KS, Birmingham AL, Louisville KY,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06787612

Phase 2, Recruiting

Radiation Free Study

for
Aortic Aneurysm
Location: Dallas TX, Birmingham AL, Philadelphia PA, Worcester MA
Sponsor: Philips Clinical & Medical Affairs Global

Sex: All

Age: 18+

Code: NCT06549348

Recruiting

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

for
HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: Dallas TX, Houston TX, San Antonio TX, St Louis MO,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07029399

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Location: Dallas TX, Plano TX, Houston TX, Kansas City MO,
Sponsor: Intellia Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06128629

Phase 3, Recruiting

Brain Injury Education and Outpatient Navigation-1stBIEN

for
Brain Injuries, Traumatic, Rehabilitation
Location: Dallas TX, Colorado Springs CO, Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 3+

Code: NCT05261477

Recruiting

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

for
Atrial Fibrillation
Location: Dallas TX, Austin TX, Oklahoma City OK, Houston TX,
Sponsor: Johns Hopkins University

Sex: All

Age: 22 - 70+

Code: NCT05836987

Phase 3, Recruiting

Comparison of Uncomplicated Candidemia Therapy Duration in Children and Adults

for
Invasive Candidiasis
Location: Dallas TX, Austin TX, Little Rock AR, St Louis MO,
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 0+

Code: NCT05763251

Recruiting

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

for
Autoimmune Hepatitis, Primary Sclerosing Cholangitis
Location: Dallas TX, St Louis MO, Indianapolis IN, Chicago IL,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT05750498

Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Dallas TX, Daphne AL, Grand Island NE, Nashville TN,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06095505

Phase 2, Recruiting

A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

for
Advanced Hepatocellular Carcinoma
Location: Dallas TX, Houston TX, Chicago IL, Charlotte NC,
Sponsor: Iterion Therapeutics

Sex: All

Age: 18+

Code: NCT05797805

Phase 1, Phase 2, Recruiting

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

for
Coagulation Disorder
Location: Dallas TX, Tulsa OK, Arkansas City AR, Englewood CO,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT05156983

Phase 3, Recruiting

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

for
Renal Cell Carcinoma
Location: Dallas TX, Lubbock TX, St Louis MO, Nashville TN,
Sponsor: HiberCell, Inc.

Sex: All

Age: 18+

Code: NCT06234605

Phase 1, Recruiting

A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

for
Phenylketonuria (PKU)
Location: Dallas TX, New Orleans LA, Nashville TN, Aurora CO,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 0+

Code: NCT05813678

Recruiting

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

for
Neutropenia
Location: Dallas TX, Fort Worth TX, Houston TX, Memphis TN,
Sponsor: X4 Pharmaceuticals

Sex: All

Age: 12+

Code: NCT06056297

Phase 3, Recruiting

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

for
Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF),
Location: Dallas TX, Houston TX, Little Rock AR, St Louis MO,
Sponsor: Cytokinetics

Sex: All

Age: 40 - 70+

Code: NCT06793371

Phase 2, Recruiting

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Dallas TX, Austin TX, Westwood KS, St Louis MO,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06619561

Phase 2, Recruiting

DETECT-RPC Universal EM Screening

for
Elder Abuse, Elder Mistreatment
Location: Dallas TX, Houston TX, Birmingham AL, Baltimore MD,
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18+

Code: NCT05958654

Recruiting

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

for
Multiple Myeloma
Location: Dallas TX, Atlanta GA, Indianapolis IN, Rochester MN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05137054

Phase 1, Recruiting